Chemoinformaics analysis of Butane-2,3-diyl diacetate
| Molecular Weight | 174.196 | nRot | 3 |
| Heavy Atom Molecular Weight | 160.084 | nRig | 14 |
| Exact Molecular Weight | 174.089 | nRing | 0 |
| Solubility: LogS | -4.349 | nHRing | 0 |
| Solubility: LogP | 4.054 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 25.9031 |
| nHD | 0 | BPOL | 19.2529 |
| QED | 0.761 |
| Synth | 1.65 |
| Natural Product Likeliness | 0.163 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.909 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.595 |
| MDCK | 0.0000275 |
| BBB | 0.2 |
| PPB | 0.99128 |
| VDSS | 0.878 |
| FU | 0.0165455 |
| CYP1A2-inh | 0.989 |
| CYP1A2-sub | 0.153 |
| CYP2c19-inh | 0.949 |
| CYP2c19-sub | 0.072 |
| CYP2c9-inh | 0.696 |
| CYP2c9-sub | 0.664 |
| CYP2d6-inh | 0.124 |
| CYP2d6-sub | 0.353 |
| CYP3a4-inh | 0.098 |
| CYP3a4-sub | 0.209 |
| CL | 11.913 |
| T12 | 0.819 |
| hERG | 0.224 |
| Ames | 0.018 |
| ROA | 0.019 |
| SkinSen | 0.962 |
| Carcinogencity | 0.164 |
| EI | 0.971 |
| Respiratory | 0.258 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.924597 |